7 employees
SynAct Pharma develops drugs for acute deterioration in inflammatory diseases.
2013
$86K
from 1 investors over 1 rounds
SynAct Pharma raised $86K on May 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)